GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (FRA:E4NA) » Definitions » Net Interest Income (for Banks)

Arovella Therapeutics (FRA:E4NA) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Arovella Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Arovella Therapeutics (FRA:E4NA) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.